Uterine Manipulators Market

Uterine Manipulators Market by Product Type (Instruments and Accessories), Usability (Re-usable and Single Use), Application (Hysterectomy and Myomectomy), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising prevalence of gynecological disorders, increasing demand for fertility treatments, increasing technological advancements, and increase in product development activities among the key market players across the globe. 

The uterine manipulators market was valued at USD 300.38 million in 2024, growing at a CAGR of 5.64% during the forecast period from 2025 to 2032 to reach USD 464.70 million by 2032. The demand for uterine manipulators is being significantly driven by the rising prevalence of gynecological disorders, such as ovarian cysts, uterine fibroids, and endometriosis. These conditions often necessitate surgical interventions, thereby boosting the need for effective surgical tools like uterine manipulators. Moreover, the increasing incidence of uterine and endometrial cancers is further contributing to the growing demand for these devices, as more patients undergo surgical procedures. Additionally, growing infertility rates and the expansion of assisted reproductive technologies (ART), including IUI and IVF, are further driving usage. In addition to these health-related factors, the market is benefiting from significant technological advancements and product innovations in uterine manipulators. Developments such as enhanced ergonomic designs, the integration of robotic technology, and the introduction of more efficient, minimally invasive tools are revolutionizing the field. As a result, these combined factors are expected to drive substantial market expansion during the forecast period from 2025 to 2032.

Uterine Manipulators Market Dynamics:

According to the data from the World Health Organization (2023), globally, endometriosis affects approximately 10% (190 million) of women and girls of reproductive age. 

Similarly, data from the Australian Government Department of Health and Aged Care (2024), revealed that at least one in nine women and those assigned female at birth in Australia were affected by endometriosis. Endometriosis is a chronic gynecological condition in which tissue similar to the uterine lining grows outside the uterus, causing severe pelvic pain, infertility, and menstrual irregularities. Surgical intervention particularly laparoscopy is often required for both diagnosis and treatment, especially when medication fails to alleviate symptoms or when fertility is compromised. Uterine manipulators play a crucial role during laparoscopic surgeries by allowing better visualization and positioning of the uterus, enabling surgeons to access difficult-to-reach pelvic areas where endometrial lesions are commonly found, such as behind the uterus or near the ovaries and fallopian tubes.

Additionally, the growing demand for fertility treatments is significantly boosting the market for uterine manipulators, as these devices play a vital role in various assisted reproductive technologies (ART) such as in vitro fertilization (IVF) and intrauterine insemination (IUI). According to the data provided by the Human Fertilization & Embryology Authority UK (2024), in 2022, approximately 52,500 patients underwent in vitro fertilization (IVF) and 3,000 received donor insemination (DI) treatment. The number of IVF cycles, including fresh and frozen embryo transfers, rose to 77,000 from around 69,000 in 2019. Uterine manipulators are essential in these procedures because they help gynecologists position the uterus with precision, enabling easier access during embryo transfer, oocyte retrieval, or hysteroscopy interventions. Their use ensures better outcomes by minimizing trauma to the uterine lining and improving the accuracy of catheter placements in ART procedures.

Moreover, the growth of the uterine manipulators market is being driven by ongoing product development and innovation by key players. Companies are launching advanced devices with improved ergonomics, enhanced flexibility, and compatibility with minimally invasive and robotic surgeries, which improve surgical efficiency and patient safety. For example, CooperSurgical’s RUMI® II system enhances access during laparoscopic hysterectomies. These innovations reduce operating time and improve outcomes, encouraging greater adoption in hospitals and clinics. Additionally, investments in product portfolio expansion and regulatory approvals are strengthening market presence, further boosting market growth.

However, the complications and risks associated with uterine manipulator devices and stringent regulatory requirements, among others are some of the key constraints that may limit the growth of the uterine manipulators market.

Uterine Manipulators Market Segment Analysis:

Uterine Manipulators Market by Product Type (Instruments and Accessories), Usability (Re-usable and Single Use), Application (Hysterectomy and Myomectomy), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the uterine manipulators market, the instruments category is expected to hold the largest market share in 2024. This can be attributed to the numerous advantages and versatile applications offered by uterine manipulator instruments, which play a critical role in improving the outcomes of gynecological surgeries. Uterine manipulators enhance surgical precision by positioning and stabilizing the uterus, thus improving the visibility of surrounding tissues. This heightened visibility enables surgeons to perform more accurate dissection and tumor removal, which is particularly important in minimally invasive surgeries such as laparoscopic or robotic procedures. The manipulator allows for better control over the uterus, facilitating its tilting or rotation to provide optimal access to the surgical site. This degree of precision is crucial in navigating complex anatomical structures, ensuring that delicate areas are carefully addressed without complications thereby escalating the overall demand of instruments.

Furthermore, by enabling the precise maneuvering of the uterus, uterine manipulators help prevent injury to adjacent organs such as the bladder, bowel, and blood vessels. This reduces the likelihood of intraoperative complications and contributes to safer, more successful surgeries. As a result, uterine manipulators not only enhance the surgeon’s ability to perform complex procedures but also improve overall surgical outcomes.

An example of such a device is the VCare® Plus by CONMED Corporation. This advanced uterine manipulator allows surgeons to maintain clear control of the anatomy, which is crucial for effective uterine manipulation. It aids in identifying key surgical landmarks, ensuring a safe, efficient, and repeatable procedure. The VCare® Plus provides superior exposure and access to the pelvic cavity, helps delineate vaginal fornices for easy identification of the colpotomy plane, and ensures the maintenance of pneumoperitoneum throughout the procedure.

North America is expected to dominate the overall uterine manipulators market:

North America is expected to lead the uterine manipulators market in 2024, driven by the rising prevalence of gynecological disorders and an increasing number of uterine and endometrial cancer cases. Technological advancements in uterine manipulators, along with continuous product development, are further fueling market growth. Additionally, the region’s sophisticated healthcare infrastructure, including state-of-the-art hospitals and specialized cancer treatment centers, supports the adoption of advanced surgical tools, positioning North America as the dominant market for uterine manipulators.

According to data from the Government of Canada (2023), endometriosis affects at least one in ten women in Canada, highlighting the growing prevalence of gynecological disorders. 

Similarly, the Society for Women’s Health Research (2023), reported that approximately 15 million women of reproductive age in the United States were affected by uterine fibroids in 2023. Uterine fibroids, which are benign growths in the uterus, and endometriosis, a condition where tissue similar to the uterine lining grows outside the uterus, both lead to various gynecological issues such as heavy menstrual bleeding, pelvic pain, and infertility. These conditions often require surgical intervention, particularly procedures like hysterectomies, myomectomies, and laparoscopic surgeries, where uterine manipulators are crucial. Uterine manipulators aid in the precise positioning and manipulation of the uterus during surgery, improving the efficiency, safety, and success of the procedure. 

Additionally, uterine cancer, the most common gynecologic cancer in the United States, further contributes to this demand. According to the American Cancer Society (2025), about 69,120 new cases of cancer of the uterus will be diagnosed in 2025 in the United States. 

As per the Canadian Cancer Society (2024), in 2024, an estimated 8,600 women were diagnosed with uterine cancer in Canada. Uterine cancer, particularly endometrial cancer, is significantly contributing to the growth of the uterine manipulator market due to the increasing need for precise and minimally invasive surgical interventions.

Uterine manipulators play a critical role in improving the ergonomics of surgical procedures, especially during laparoscopic surgeries. They allow for better positioning and stabilization of the uterus, ensuring effective access to the surgical site. As the incidence of uterine cancer continues to rise, the demand for uterine manipulators is set to grow in the region, supporting safer, more precise surgical interventions. Uterine manipulators play a critical role in these surgeries by providing optimal uterine positioning, enhancing visualization, and allowing surgeons to perform complex procedures with greater precision and control. Their use is especially important in laparoscopic and robotic-assisted surgeries, which are preferred for uterine cancer treatment due to their reduced recovery time, lower complication rates, and improved patient outcomes.

Thus, the factors mentioned above are expected to boost the overall market of uterine manipulators across the region.

Uterine Manipulators Market Key Players: 

Some of the key market players operating in the uterine manipulators market include The Cooper Companies Inc., CONMED Corporation, KARL STORZ, Olympus Corporation, Richard Wolf GmbH, Hologic, Inc., Lumenis Be Ltd., B. Braun Melsungen AG, Medline Industries, LP, EndoMed Systems GmbH, Laborie, Conkin Surgical Instrument Ltd., Peters Surgical, IndoSurgicals Private Limited, Utah Medical Products, Inc., Purple Surgical, Stille AB, Aspen Surgical Products, Inc., Hangzhou Kangji Medical Instrument Co., Ltd., Advin Health Care, and others.

Recent Developmental Activities in the Uterine Manipulators Market:

• In January 2023, Organon made a strategic investment in Claria Medical to support the development of an investigational medical device aimed at enhancing minimally invasive hysterectomy procedures. This investment reflected Organon’s commitment to advancing women's health by supporting innovative technologies that improve surgical outcomes and reduce recovery times for patients. The partnership will focus on the development of a device designed to streamline the hysterectomy process, making it safer, more precise, and less invasive.

Key Takeaways from the Uterine Manipulators Market Report Study

• Market size analysis for current uterine manipulators market size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the uterine manipulators market.
• Various opportunities available for the other competitors in the uterine manipulators Market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current uterine manipulators market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for uterine manipulators market growth in the coming future?

Target Audience Who Can be benefited from this Uterine Manipulators Market Report Study

• Uterine manipulator product providers
• Research organizations and consulting companies 
• Uterine manipulators related organizations, associations, forums, and other alliances.
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in uterine manipulators
• Various end-users who want to know more about the uterine manipulators market and the latest technological developments in the uterine manipulators market.  

Frequently Asked Questions for the Uterine Manipulators Market:

1. What are uterine manipulators?

• Uterine manipulators are medical devices used during gynecological surgeries to assist in positioning, and stabilizing the uterus. These instruments are particularly valuable in procedures like hysterectomies, including those performed to treat uterine, cervical, or endometrial cancers. The primary purpose of a uterine manipulator is to provide better visibility and access to the surgical site, allowing the surgeon to safely navigate and perform precise surgical interventions.

2. What is the market for uterine manipulators?

• The uterine manipulators market was valued at USD 300.38 million in 2024, growing at a CAGR of 5.64% during the forecast period from 2025 to 2032 to reach USD 464.70 million by 2032.

3. What are the drivers for the uterine manipulators market?

• The demand for uterine manipulators is being significantly driven by the rising prevalence of gynecological disorders, such as ovarian cysts, uterine fibroids, and endometriosis. These conditions often necessitate surgical interventions, thereby boosting the need for effective surgical tools like uterine manipulators. Moreover, the increasing incidence of uterine and endometrial cancers is further contributing to the growing demand for these devices, as more patient undergo surgical procedures. Additionally, growing infertility rates and the expansion of assisted reproductive technologies (ART), including IUI and IVF, are further driving usage. In addition to these health-related factors, the market is benefiting from significant technological advancements and product innovations in uterine manipulators. Developments such as enhanced ergonomic designs, the integration of robotic technology, and the introduction of more efficient, minimally invasive tools are revolutionizing the field. As a result, these combined factors are expected to drive substantial market expansion during the forecast period from 2025 to 2032.

4. Who are the key players operating in the uterine manipulators market?

• Some of the key market players operating in the uterine manipulators market include The Cooper Companies Inc., CONMED Corporation, KARL STORZ, Olympus Corporation, Richard Wolf GmbH, Hologic, Inc., Lumenis Be Ltd., B. Braun Melsungen AG, Medline Industries, LP, EndoMed Systems GmbH, Laborie, Conkin Surgical Instrument Ltd., Peters Surgical, IndoSurgicals Private Limited, Utah Medical Products, Inc., Purple Surgical, Stille AB, Aspen Surgical Products, Inc., Hangzhou Kangji Medical Instrument Co., Ltd., Advin Health Care, and others.

5. Which region has the highest share in the Uterine Manipulators market?

• North America is expected to lead the uterine manipulators market in 2024, driven by the rising prevalence of gynecological disorders and an increasing number of uterine and endometrial cancer cases. Technological advancements in uterine manipulators, along with continuous product development, are further fueling market growth. Additionally, the region’s sophisticated healthcare infrastructure, including state-of-the-art hospitals and specialized cancer treatment centers, supports the adoption of advanced surgical tools, positioning North America as the dominant market for uterine manipulators.